Advanced

A Cost Effectiveness Analysis Of A General Vaccination Programme With The New 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein-D Conjugate Vaccine (Phid-Cv) In Sweden

Bergman, Annika; Borg, Sixten LU ; Sobocki, P. and Persson, U. (2009) In Value in Health 12(3). p.165-165
Please use this url to cite or link to this publication:
author
publishing date
type
Contribution to journal
publication status
published
subject
in
Value in Health
volume
12
issue
3
pages
165 - 165
publisher
Wiley-Blackwell
external identifiers
  • wos:000265236700818
ISSN
1098-3015
language
English
LU publication?
no
id
9bc80028-6108-48ef-8337-2d2fd0259c92 (old id 1426530)
alternative location
http://www.sciencedirect.com/science/article/pii/S1098301510738869
date added to LUP
2009-06-25 14:36:22
date last changed
2016-06-29 09:06:01
@misc{9bc80028-6108-48ef-8337-2d2fd0259c92,
  author       = {Bergman, Annika and Borg, Sixten and Sobocki, P. and Persson, U.},
  issn         = {1098-3015},
  language     = {eng},
  note         = {Conference Abstract},
  number       = {3},
  pages        = {165--165},
  publisher    = {Wiley-Blackwell},
  series       = {Value in Health},
  title        = {A Cost Effectiveness Analysis Of A General Vaccination Programme With The New 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein-D Conjugate Vaccine (Phid-Cv) In Sweden},
  volume       = {12},
  year         = {2009},
}